TNF and rheumatoid arthritis: Patients included in the ARRIVE study exhibited levels of baseline RA disease activity closer to those commonly encountered in daily practice, with lower mean swollen and tender joint counts.1, 2, 16 Importantly, upon discontinuation of their anti-TNF treatment, patients were able to switch directly to abatacept on their next scheduled anti-TNF dose and were not required to undergo a washout.